Kymera Therapeutics, Inc. (KYMR)
106.78
-5.30
(-4.73%)
USD |
NASDAQ |
Oct 13, 16:00
106.73
-0.05
(-0.05%)
After-Hours: 20:00
Kymera Therapeutics Price : 106.78 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 111.61 | 113.13 | 110.52 | 112.08 | 537523.0 |
| Oct 09, 2026 | 109.54 | 115.82 | 107.46 | 112.40 | 1.305M |
| Oct 08, 2026 | 106.52 | 110.04 | 104.19 | 109.30 | 1.045M |
| Oct 07, 2026 | 104.58 | 108.68 | 103.45 | 108.35 | 1.167M |
| Oct 06, 2026 | 111.03 | 111.04 | 101.74 | 105.98 | 960714.0 |
| Oct 05, 2026 | 108.38 | 109.92 | 103.33 | 109.85 | 729726.0 |
| Oct 02, 2026 | 111.23 | 111.23 | 106.53 | 107.39 | 870206.0 |
| Oct 01, 2026 | 111.79 | 116.20 | 109.41 | 110.12 | 1.051M |
| Sep 30, 2026 | 110.74 | 115.69 | 108.03 | 111.79 | 1.023M |
| Sep 29, 2026 | 110.54 | 111.92 | 108.97 | 110.51 | 448209.0 |
| Sep 28, 2026 | 111.95 | 113.60 | 110.51 | 112.00 | 723653.0 |
| Sep 25, 2026 | 115.99 | 116.20 | 111.42 | 111.95 | 698434.0 |
| Sep 24, 2026 | 115.28 | 116.40 | 111.36 | 115.81 | 841723.0 |
| Sep 23, 2026 | 121.29 | 123.00 | 112.91 | 115.47 | 969616.0 |
| Sep 22, 2026 | 119.03 | 122.37 | 117.88 | 122.06 | 779427.0 |
| Sep 21, 2026 | 117.75 | 119.53 | 116.61 | 117.67 | 636938.0 |
| Sep 18, 2026 | 119.06 | 119.06 | 116.36 | 117.75 | 1.900M |
| Sep 17, 2026 | 119.12 | 122.13 | 118.27 | 118.48 | 570489.0 |
| Sep 16, 2026 | 113.06 | 117.43 | 112.88 | 116.33 | 655793.0 |
| Sep 15, 2026 | 114.50 | 114.50 | 110.29 | 113.15 | 900978.0 |
| Sep 14, 2026 | 116.01 | 117.85 | 114.32 | 114.63 | 499014.0 |
| Sep 11, 2026 | 118.40 | 119.93 | 113.74 | 114.96 | 574186.0 |
| Sep 10, 2026 | 116.05 | 119.63 | 114.35 | 117.00 | 734300.0 |
| Sep 09, 2026 | 115.34 | 120.66 | 113.18 | 115.43 | 767425.0 |
| Sep 08, 2026 | 114.41 | 120.22 | 113.97 | 116.47 | 631822.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 58.14 |
| Oncolytics Biotech, Inc. | 0.4898 |
| Sangamo Therapeutics, Inc. | 0.15 |
| Sarepta Therapeutics, Inc. | 16.50 |
| Anixa Biosciences, Inc. | 2.70 |
Price Related Metrics
| PS Ratio | 94.81 |
| Price to Book Value | 5.857 |
| Earnings Yield | -3.04% |
| Market Cap | 8.840B |